|5.16||-0.02 / -0.39%|
Data as of 3:59pm ET
|5.16||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +132.56% increase from the last price of 5.16.
The current consensus among 8 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.